347 related articles for article (PubMed ID: 28030556)
1. Hepatocyte Hypoxia Inducible Factor-1 Mediates the Development of Liver Fibrosis in a Mouse Model of Nonalcoholic Fatty Liver Disease.
Mesarwi OA; Shin MK; Bevans-Fonti S; Schlesinger C; Shaw J; Polotsky VY
PLoS One; 2016; 11(12):e0168572. PubMed ID: 28030556
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte HIF-1 and Intermittent Hypoxia Independently Impact Liver Fibrosis in Murine Nonalcoholic Fatty Liver Disease.
Mesarwi OA; Moya EA; Zhen X; Gautane M; Zhao H; Wegbrans Giró P; Alshebli M; McCarley KE; Breen EC; Malhotra A
Am J Respir Cell Mol Biol; 2021 Oct; 65(4):390-402. PubMed ID: 34003729
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia inducible factor-1 promotes liver fibrosis in nonalcoholic fatty liver disease by activating PTEN/p65 signaling pathway.
Han J; He Y; Zhao H; Xu X
J Cell Biochem; 2019 Sep; 120(9):14735-14744. PubMed ID: 31009107
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells.
Hernández A; Reyes D; Geng Y; Arab JP; Cabrera D; Sepulveda R; Solis N; Buist-Homan M; Arrese M; Moshage H
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165857. PubMed ID: 32512191
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Hypoxia Inducible Factor 1α Subunit Pathway in Steatotic Liver Contributes to Formation of Cholesterol Gallstones.
Asai Y; Yamada T; Tsukita S; Takahashi K; Maekawa M; Honma M; Ikeda M; Murakami K; Munakata Y; Shirai Y; Kodama S; Sugisawa T; Chiba Y; Kondo Y; Kaneko K; Uno K; Sawada S; Imai J; Nakamura Y; Yamaguchi H; Tanaka K; Sasano H; Mano N; Ueno Y; Shimosegawa T; Katagiri H
Gastroenterology; 2017 May; 152(6):1521-1535.e8. PubMed ID: 28088462
[TBL] [Abstract][Full Text] [Related]
6. Chemical hypoxia induces pro-inflammatory signals in fat-laden hepatocytes and contributes to cellular crosstalk with Kupffer cells through extracellular vesicles.
Hernández A; Geng Y; Sepúlveda R; Solís N; Torres J; Arab JP; Barrera F; Cabrera D; Moshage H; Arrese M
Biochim Biophys Acta Mol Basis Dis; 2020 Jun; 1866(6):165753. PubMed ID: 32126269
[TBL] [Abstract][Full Text] [Related]
7. microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis.
Csak T; Bala S; Lippai D; Satishchandran A; Catalano D; Kodys K; Szabo G
Liver Int; 2015 Feb; 35(2):532-41. PubMed ID: 25040043
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol Induces Nrf-2- and HIF-1
Kaminsky-Kolesnikov Y; Rauchbach E; Abu-Halaka D; Hahn M; García-Ruiz C; Fernandez-Checa JC; Madar Z; Tirosh O
Oxid Med Cell Longev; 2020; 2020():5393761. PubMed ID: 32566088
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific hypoxia-inducible factor-1α is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice.
Nath B; Levin I; Csak T; Petrasek J; Mueller C; Kodys K; Catalano D; Mandrekar P; Szabo G
Hepatology; 2011 May; 53(5):1526-37. PubMed ID: 21520168
[TBL] [Abstract][Full Text] [Related]
10. Lysyl Oxidase as a Serum Biomarker of Liver Fibrosis in Patients with Severe Obesity and Obstructive Sleep Apnea.
Mesarwi OA; Shin MK; Drager LF; Bevans-Fonti S; Jun JC; Putcha N; Torbenson MS; Pedrosa RP; Lorenzi-Filho G; Steele KE; Schweitzer MA; Magnuson TH; Lidor AO; Schwartz AR; Polotsky VY
Sleep; 2015 Oct; 38(10):1583-91. PubMed ID: 26085300
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia exacerbates nonalcoholic fatty liver disease via the HIF-2α/PPARα pathway.
Chen J; Chen J; Fu H; Li Y; Wang L; Luo S; Lu H
Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E710-E722. PubMed ID: 31430204
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
[TBL] [Abstract][Full Text] [Related]
13. NOD2 in hepatocytes engages a liver-gut axis to protect against steatosis, fibrosis, and gut dysbiosis during fatty liver disease in mice.
Cavallari JF; Pokrajac NT; Zlitni S; Foley KP; Henriksbo BD; Schertzer JD
Am J Physiol Endocrinol Metab; 2020 Aug; 319(2):E305-E314. PubMed ID: 32516028
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis.
Zou A; Magee N; Deng F; Lehn S; Zhong C; Zhang Y
J Biol Chem; 2018 Jun; 293(22):8656-8671. PubMed ID: 29666185
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression in hepatocytes attenuates non-alcoholic steatohepatitis and liver fibrosis in mice.
Motiño O; Agra N; Brea Contreras R; Domínguez-Moreno M; García-Monzón C; Vargas-Castrillón J; Carnovale CE; Boscá L; Casado M; Mayoral R; Valdecantos MP; Valverde ÁM; Francés DE; Martín-Sanz P
Biochim Biophys Acta; 2016 Sep; 1862(9):1710-23. PubMed ID: 27321932
[TBL] [Abstract][Full Text] [Related]
16. HFD and HFD-provoked hepatic hypoxia act as reciprocal causation for NAFLD via HIF-independent signaling.
Zhang X; Huang C; Li X; Shangguan Z; Wei W; Liu S; Yang S; Liu Y
BMC Gastroenterol; 2020 Nov; 20(1):366. PubMed ID: 33143650
[TBL] [Abstract][Full Text] [Related]
17. HIV coinfection exacerbates HBV-induced liver fibrogenesis through a HIF-1α- and TGF-β1-dependent pathway.
Xu M; Warner C; Duan X; Cheng Z; Jeyarajan AJ; Li W; Wang Y; Shao T; Salloum S; Chen PJ; Yu X; Chung RT; Lin W
J Hepatol; 2024 Jun; 80(6):868-881. PubMed ID: 38311121
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-Hepatocyte-Stellate Cell Cross Talk Promotes Hepatocyte Injury and Fibrosis in Experimental Nonalcoholic Steatohepatitis.
Pulli B; Ali M; Iwamoto Y; Zeller MW; Schob S; Linnoila JJ; Chen JW
Antioxid Redox Signal; 2015 Dec; 23(16):1255-69. PubMed ID: 26058518
[TBL] [Abstract][Full Text] [Related]
19. CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease.
Chen J; Hao Y; Xu P; Bian D; Han L; Wu X; Zhuang Z; Wang J; Luo Y
Biochem Biophys Res Commun; 2023 Jul; 667():120-126. PubMed ID: 37216827
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte-specific deletion of ARNT (aryl hydrocarbon Receptor Nuclear Translocator) results in altered fibrotic gene expression in the thioacetamide model of liver injury.
Scott C; Cha K; Rao R; Liddle C; George J; Gunton JE
PLoS One; 2015; 10(3):e0121650. PubMed ID: 25812120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
